ImmuPharma plc
IMM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £237 | £208 | £668 | £1,649 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £429 | £452 | £649 | £373 |
| Inventory | £0 | £0 | £0 | £0 |
| Other Curr. Assets | £219 | £683 | £1,022 | £1,323 |
| Total Curr. Assets | £885 | £1,343 | £2,339 | £3,346 |
| Property Plant & Equip (Net) | £82 | £102 | £390 | £353 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £10 | £448 | £474 | £478 |
| Long-Term Investments | £0 | £644 | £772 | £1,821 |
| Tax Assets | £0 | £0 | -£772 | -£1,821 |
| Other NC Assets | £0 | £185 | £772 | £1,821 |
| Total NC Assets | £92 | £1,378 | £1,636 | £2,652 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £977 | £2,721 | £3,975 | £5,998 |
| Liabilities | – | – | – | – |
| Payables | £511 | £776 | £1,071 | £1,156 |
| Short-Term Debt | £0 | £0 | £0 | £1 |
| Tax Payable | £118 | £120 | £180 | £269 |
| Deferred Revenue | £0 | £0 | -£380 | -£428 |
| Other Curr. Liab. | £891 | £769 | £580 | £586 |
| Total Curr. Liab. | £1,520 | £1,665 | £1,451 | £1,584 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £1,451 | £1,157 |
| Other Liabilities | £0 | £0 | -£1,451 | -£1,157 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £1,520 | £1,665 | £1,451 | £1,584 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £29,813 | £29,813 | £28,983 | £28,498 |
| Retained Earnings | -£65,911 | -£64,083 | -£61,115 | -£56,582 |
| AOCI | £0 | £6,009 | £5,868 | £5,259 |
| Other Equity | £35,555 | £29,317 | £28,788 | £27,237 |
| Total Equity | -£543 | £1,056 | £2,523 | £4,413 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £977 | £2,721 | £3,975 | £5,998 |
| Net Debt | -£237 | -£208 | -£668 | -£1,649 |